 adjuv chemotherapi breast cancer mani women breast cancer earli detect surgic techniqu micrometastas present diagnosi adjuv therapi disease-fre interv patient overal surviv mani combin chemotherapi standard form adjuv treatment premenopaus women breast cancer posit lymph node primari therapi minim toxic disease-fre overal surviv result impress clear-cut postmenopaus women woman neg lymph node long-term toxic adjuv chemotherapi second malign cardiac dysfunct complic rare chemotherapi patient benefit slight innov like standard adjuv therapi decis risk assess new prognost indic growth fraction oncogen express investig dose intensif bone marrow growth factor autolog stem-cel support